You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-CD37, monoclonal antibodies, DuoHexabody®

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nephrotic Syndrome Trial in Genova (Rituximab Biosimilar ABP 798, Daratumumab)

Not yet recruiting
  • Nephrotic Syndrome
  • Genova, Italy
    IRCCS G. Gaslini
Jan 19, 2023

HBV Trial in Paris (o receive treatment with anti-CD20 (rituximab or ocrelizumab) and to be vaccinated against hepatitis B)

Recruiting
  • HBV
  • o receive treatment with anti-CD20 (rituximab or ocrelizumab) and to be vaccinated against hepatitis B
  • Paris, Ile De France, France
    Valérie POURCHER
Feb 2, 2021

B-cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Hangzhou (QN-019a, Rituximab, Cyclophosphamid)

Recruiting
  • B-cell Lymphoma
  • B-cell Acute Lymphoblastic Leukemia
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical College of Zhejiang Uni
May 17, 2022

Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in United States (FT596, Cyclophosphamide, Fludarabine)

Recruiting
  • Lymphoma, B-Cell
  • Chronic Lymphocytic Leukemia
  • Chicago, Illinois
  • +8 more
Jun 21, 2022

Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (GEN3009, Epcoritamab)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • +7 more
  • GEN3009
  • Epcoritamab
  • Tucson, Arizona
  • +31 more
Jul 1, 2022

DLBCL Trial (R2-CHOP(Lenalidomide,Rituximab,cyclophosphamide,hydroxyldaunorubicin,Vincristine,Prednisone)))

Not yet recruiting
  • DLBCL
  • (no location specified)
Apr 12, 2021

Immune Disease Trial in Lille (Monoclonal anti-cd303 antibody)

Completed
  • Immune Disease
  • Monoclonal anti-cd303 antibody
  • Lille, France
    Hôpital Claude Huriez, CHU
Aug 26, 2020

Nephrotic Syndrome Steroid-Dependent Trial in Genova (Rituximab Biosimilar, Mycophenolate Mofetil)

Terminated
  • Nephrotic Syndrome Steroid-Dependent
  • Rituximab Biosimilar
  • Mycophenolate Mofetil
  • Genova, Italy
    IRCCS Istituto Giannina Gaslini
Sep 10, 2020

Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia Trial in Australia,

Recruiting
  • Follicular Lymphoma
  • +7 more
  • Louisville, Kentucky
  • +4 more
Mar 11, 2022

Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in

Not yet recruiting
  • Ovarian Clear Cell Adenocarcinoma
  • +14 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 16, 2022

Metastatic Gastric Cancer Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab

Recruiting
  • Metastatic Gastric Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • Nivolumab Injection
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Aug 23, 2023

Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Sacramento (Anti-PD-L1 Monoclonal Antibody MPDL3280A,

Terminated
  • Recurrent Non-Small Cell Lung Carcinoma
  • Stage IV Non-Small Cell Lung Cancer
  • Anti-PD-L1 Monoclonal Antibody MPDL3280A
  • Stereotactic Body Radiation Therapy
  • Sacramento, California
    University of California Davis
Aug 2, 2022

LEUKEMIA Trial in Houston (CAMPATH-1H, Anti-CD45, Ara-C)

Completed
  • LEUKEMIA
  • Houston, Texas
  • +1 more
Jan 15, 2020

Safety and Efficacy Trial in Suzhou (Basiliximab, Vedolizumab)

Recruiting
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Sep 27, 2023

Nephrotic Syndrome Trial in Ranica (Blood sampling)

Recruiting
  • Nephrotic Syndrome
  • Blood sampling
  • Ranica, BG, Italy
    Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Jan 25, 2023

Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

Not yet recruiting
  • Monoclonal Gammopathy of Uncertain Significance
  • Zanubrutinib Oral Product
  • Utrecht, Netherlands
    University Medical Center Utrecht
Jul 6, 2023

Obstetrical History and Anti-HLA Antibodies Level

Not yet recruiting
  • Blood Donors
  • Anti-HLA Antibody
  • Obstetrical history
  • Anti-HLA Antibody tests
  • Bordeaux, France
    Etablissement Français du Sang Nouvelle Aquitaine
Aug 25, 2023

DLBCL, Not Otherwise Specified, High Grade B-Cell Lymphoma, Transformed Indolent B-Cell Non-Hodgkin Lymphoma to DLBCL Trial

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • +2 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Sep 5, 2023

Mantle Cell Lymphoma Trial in Duarte (drug, procedure, biological)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Duarte, California
    City of Hope Medical Center
Sep 20, 2023

Lymphoma, Non-Hodgkin, Lymphoma, T-Cell Trial in Najing (Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Lymphoma, T-Cell
  • Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection
  • Najing, Jiangsu, China
    Jiangsu Provincial People's Hospital
Sep 26, 2022

Colon Carcinoma Metastatic in the Liver, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Atlanta, Rochester

Active, not recruiting
  • Colon Carcinoma Metastatic in the Liver
  • +13 more
  • Anti-SEMA4D Monoclonal Antibody VX15/2503
  • +3 more
  • Atlanta, Georgia
  • +3 more
Dec 15, 2021

Intestinal Transglutaminase Antibodies in Celiac Disease

Completed
  • Celiac Disease
  • Evaluation of diagnostic accuracy of anti-ttg-m
  • Trieste, Italy
    IRCCS materno infantile Burlo Garofolo
Apr 11, 2023

Non-Malignant Tumor Trial in Seattle (biological, drug, radiation, procedure)

Recruiting
  • Non-Malignant Neoplasm
  • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • TPO-RAs
  • TPO-RAs combining anti-CD 20 monoclonal antibody
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Feb 7, 2023

Nodular Lymphocyte Predominant Hodgkin Lymphoma, Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma, Refractory Nodular

Not yet recruiting
  • Nodular Lymphocyte Predominant Hodgkin Lymphoma
  • +2 more
  • Biopsy
  • +9 more
  • (no location specified)
Jun 1, 2023